Literature DB >> 20151145

Validating population-based registers for ALS: how accurate is death certification?

Loraine Yeo1, Catherine Lynch, Orla Hardiman.   

Abstract

The purpose of this study was to determine the accuracy of death certification for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) as recorded by the Central Statistics Office in the Republic of Ireland, and to examine its utility in capture-recapture analysis. The database of the Irish Central Statistics Office (CSO) was searched for death certificates of individuals over 15 years of age for whom ALS/MND (ICD9) was listed as a primary, secondary or tertiary cause of death from 2002 to 2006. This dataset was compared with mortality data from the Irish Register for ALS/MND for the same period. Three hundred ninety-eight cases with a diagnosis of ALS were identified through the CSO. The cause of death as identified by the CSO was 318 out of 398 (80%) cases known to the Register during the study period. ALS/MND was listed as a cause of death by the CSO in 79 (20%) cases that were unknown to the ALS/MND Register. Of these, ALS/MND was listed as a secondary/tertiary cause of death in 76, and 75% of all such deaths occurred in rural areas. Capture-recapture analysis using the CSO and ALS Register as independent datasets generated a likely over-estimation of the crude incidence of ALS from 2.1/100,000 to 3.45/100,000 in Ireland. Population-based registers are most accurate when ascertaining from a wide network of inter-dependent sources. Death certification for ALS/MND lacks both sensitivity and specificity. Capture-recapture exercises using such data sources are likely to over-estimate the true incidence of disease.

Entities:  

Mesh:

Year:  2010        PMID: 20151145     DOI: 10.1007/s00415-010-5494-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  17 in total

1.  Capture-recapture methods--useful or misleading?

Authors:  K Tilling
Journal:  Int J Epidemiol       Date:  2001-02       Impact factor: 7.196

Review 2.  Ethnic variation in the incidence of ALS: a systematic review.

Authors:  Simon Cronin; Orla Hardiman; Bryan J Traynor
Journal:  Neurology       Date:  2007-03-27       Impact factor: 9.910

3.  The reliability of death certificate reporting for amyotrophic lateral sclerosis.

Authors:  P M Hoffman; J A Brody
Journal:  J Chronic Dis       Date:  1971-06

4.  Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study.

Authors:  B J Traynor; M B Codd; B Corr; C Forde; E Frost; O Hardiman
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

5.  Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease.

Authors:  A M Chancellor; R J Swingler; H Fraser; J A Clarke; C P Warlow
Journal:  J Epidemiol Community Health       Date:  1993-04       Impact factor: 3.710

Review 6.  The management of amyotrophic lateral sclerosis.

Authors:  Julie Phukan; Orla Hardiman
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

7.  Multiple sclerosis and motor neurone disease: survival and how certified after death.

Authors:  F O'Malley; G Dean; M Elian
Journal:  J Epidemiol Community Health       Date:  1987-03       Impact factor: 3.710

8.  Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study.

Authors:  T Zaldivar; J Gutierrez; G Lara; M Carbonara; G Logroscino; O Hardiman
Journal:  Neurology       Date:  2009-05-12       Impact factor: 9.910

9.  The incidence of motor nueron disease in Scotland.

Authors:  Raeburn B Forbes; Shuna Colville; John Parratt; Robert J Swingler
Journal:  J Neurol       Date:  2007-04-10       Impact factor: 4.849

10.  Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004.

Authors:  O O'Toole; B J Traynor; P Brennan; C Sheehan; E Frost; B Corr; O Hardiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-07-18       Impact factor: 10.154

View more
  11 in total

1.  An investigation into nature and extent of errors within the Irish Vital Statistics mortality database.

Authors:  Frank Houghton; Sharon Houghton
Journal:  Ir J Med Sci       Date:  2018-10-18       Impact factor: 1.568

2.  ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics.

Authors:  Hiroshi Mitsumoto; Pam Factor-Litvak; Howard Andrews; Raymond R Goetz; Leslie Andrews; Judith G Rabkin; Martin McElhiney; Jeri Nieves; Regina M Santella; Jennifer Murphy; Jonathan Hupf; Jess Singleton; David Merle; Mary Kilty; Daragh Heitzman; Richard S Bedlack; Robert G Miller; Jonathan S Katz; Dallas Forshew; Richard J Barohn; Eric J Sorenson; Bjorn Oskarsson; J Americo M Fernandes Filho; Edward J Kasarskis; Catherine Lomen-Hoerth; Tahseen Mozaffar; Yvonne D Rollins; Sharon P Nations; Andrea J Swenson; Jeremy M Shefner; Jinsy A Andrews; Boguslawa A Koczon-Jaremko
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-02-24       Impact factor: 4.092

3.  Intakes of caffeine, coffee and tea and risk of amyotrophic lateral sclerosis: Results from five cohort studies.

Authors:  Elinor Fondell; É Ilis J O'Reilly; Kathryn C Fitzgerald; Guido J Falcone; Laurence N Kolonel; Yikyung Park; Susan M Gapstur; Alberto Ascherio
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-03-30       Impact factor: 4.092

4.  Comparison of diagnoses of amyotrophic lateral sclerosis by use of death certificates and hospital discharge data in the Danish population.

Authors:  Marianthi-Anna Kioumourtzoglou; Ryan M Seals; Liselotte Himmerslev; Ole Gredal; Johnni Hansen; Marc G Weisskopf
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-05-06       Impact factor: 4.092

5.  Development of a prognostic model of respiratory insufficiency or death in amyotrophic lateral sclerosis.

Authors:  Jason Ackrivo; John Hansen-Flaschen; E Paul Wileyto; Richard J Schwab; Lauren Elman; Steven M Kawut
Journal:  Eur Respir J       Date:  2019-04-18       Impact factor: 16.671

Review 6.  A systematic review on the risk of neurodegenerative diseases and neurocognitive disorders in professional and varsity athletes.

Authors:  G Bellomo; P Piscopo; M Corbo; E Pupillo; G Stipa; E Beghi; N Vanacore; E Lacorte
Journal:  Neurol Sci       Date:  2022-08-17       Impact factor: 3.830

Review 7.  Current pathways for epidemiological research in amyotrophic lateral sclerosis.

Authors:  Pam Factor-Litvak; Ammar Al-Chalabi; Alberto Ascherio; Walter Bradley; Adriano Chío; Ralph Garruto; Orla Hardiman; Freya Kamel; Edward Kasarskis; Ann McKee; Imaharu Nakano; Lorene M Nelson; Andrew Eisen
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-05       Impact factor: 4.092

8.  Case-control study of occupational exposure to electric shocks and magnetic fields and mortality from amyotrophic lateral sclerosis in the US, 1991-1999.

Authors:  Ximena Vergara; Gabor Mezei; Leeka Kheifets
Journal:  J Expo Sci Environ Epidemiol       Date:  2014-06-11       Impact factor: 5.563

Review 9.  Accuracy of routinely-collected healthcare data for identifying motor neurone disease cases: A systematic review.

Authors:  Sophie Horrocks; Tim Wilkinson; Christian Schnier; Amanda Ly; Rebecca Woodfield; Kristiina Rannikmäe; Terence J Quinn; Cathie L M Sudlow
Journal:  PLoS One       Date:  2017-02-28       Impact factor: 3.240

10.  Accuracy of Death Certificates and Assessment of Factors for Misclassification of Underlying Cause of Death.

Authors:  Makiko Naka Mieno; Noriko Tanaka; Tomio Arai; Takuya Kawahara; Aya Kuchiba; Shizukiyo Ishikawa; Motoji Sawabe
Journal:  J Epidemiol       Date:  2015-12-05       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.